HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 323 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,878 | +87.8% | 33 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | -66.7% | 33 | -56.0% | 0.00% | – |
| Q2 2022 | $3,000 | +50.0% | 75 | +21.0% | 0.00% | – |
| Q1 2022 | $2,000 | 0.0% | 62 | 0.0% | 0.00% | – |
| Q4 2021 | $2,000 | -66.7% | 62 | -56.6% | 0.00% | -100.0% |
| Q3 2021 | $6,000 | -33.3% | 143 | -25.5% | 0.00% | 0.0% |
| Q2 2021 | $9,000 | 0.0% | 192 | -14.7% | 0.00% | 0.0% |
| Q1 2021 | $9,000 | +28.6% | 225 | +36.4% | 0.00% | 0.0% |
| Q4 2020 | $7,000 | +250.0% | 165 | +111.5% | 0.00% | – |
| Q3 2020 | $2,000 | +100.0% | 78 | +105.3% | 0.00% | – |
| Q2 2020 | $1,000 | -50.0% | 38 | -58.7% | 0.00% | -100.0% |
| Q1 2020 | $2,000 | +100.0% | 92 | +17.9% | 0.00% | – |
| Q4 2019 | $1,000 | – | 78 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
| BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
| SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
| SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
| Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
| MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
| DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
| Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |
| Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |